Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Superseded

This Document Has Been Replaced By: Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children

October 3, 2008
By United States. Advisory Committee on Immunization Practices. ...
Source: MMWR. Morbidity and mortality weekly report. 2008; 57(39):1079-80.

[PDF-1.60 MB]

English

Details You May Also Like

Details:

Alternative Title:

MMWR. Morbidity and mortality weekly report
Corporate Authors:

United States. Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.)

United States. Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.) Less -
Description:

On June 20, 2008 the Food and Drug Administration (FDA) licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP), inactivated poliovirus vaccine (IPV), and Haemophilus influenzae type b conjugate (tetanus toxoid [TT] conjugate) vaccine, DTaP-IPV/Hib (Pentacel, Sanofi Pasteur, Swiftwater, Pennsylvania), for use as a four-dose series in infants and children at ages 2, 4, 6, and 15-18 months. This report summarizes the indications for Pentacel and provides guidance from the Advisory Committee on Immunization Practices (ACIP) for its use.
Subjects:

[+]

Child, Preschool Diphtheria-Tetanus-acellular Pertussis Vaccines Diphtheria-Tetanus-Pertussis Vaccine Haemophilus Vaccines Humans Immunization Schedule Infant Licensure Poliovirus Vaccine, Inactivated Vaccines, Combined
Source:

MMWR. Morbidity and mortality weekly report. 2008; 57(39):1079-80.
Pubmed ID:

18830213
Document Type:

Journal Article
Place as Subject:

United States
Volume:

57
Issue:

39
Collection(s):

Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report (MMWR) Guidelines and Recommendations
Main Document Checksum:

[+]

urn:sha256:24865027db75e45262c9ca2eaf6a948dcaa520b0513a3ce6cc43843ffbbf938c
Download URL:

https://stacks.cdc.gov/view/cdc/7435/cdc_7435_DS1.pdf
File Type:

No Additional Files

More +

Superseded

Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children

Details:

Supporting Files

You May Also Like